SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Masahiro Asaka, Mototsugu Kato, Shin-ichi Takahashi, Yoshihiro Fukuda, Toshiro Sugiyama, Hiroyoshi Ota, Naomi Uemura, Kazunari Murakami, Kiichi Satoh, Kentaro Sugano, Guidelines for the Management of Helicobacter pylori Infection in Japan: 2009 Revised Edition, Helicobacter, 2010, 15, 1
  2. 2
    Ning Zhou, Wei-xing Chen, Wei Zhang, Lan Li, Xi Jin, You-ming Li, Is short-term therapy really sufficient to eradicate Helicobacter pylori infection?, Journal of Zhejiang University SCIENCE B, 2010, 11, 9, 690

    CrossRef

  3. 3
    Asghar Qasim, Colm A. O’Morain, Humphrey J. O’Connor, Helicobacter pylori eradication: role of individual therapy constituents and therapy duration, Fundamental & Clinical Pharmacology, 2009, 23, 1
  4. 4
    Jyh-Chin Yang, Yu-Fan Yang, Yow-Shieng Uang, Chun-Jung Lin, Teh-Hong Wang, Pharmacokinetic– pharmacodynamic analysis of the role of CYP2C19 genotypes in short-term rabeprazole-based triple therapy against Helicobacter pylori, British Journal of Clinical Pharmacology, 2009, 67, 5
  5. 5
    Edoardo G. Giannini, Claudio Bilardi, Pietro Dulbecco, Mario Mamone, Maria L. Santi, Roberto Testa, Carlo Mansi, Vincenzo Savarino, Can Helicobacter pylori Eradication Regimens be Shortened in Clinical Practice? An Open-label, Randomized, Pilot Study of 4 and 7-day Triple Therapy With Rabeprazole, High-dose Levofloxacin, and Tinidazole, Journal of Clinical Gastroenterology, 2006, 40, 6, 515

    CrossRef

  6. 6
    Hajime Isomoto, Hiroaki Ueno, Vladimir A. Saenko, Muhtashan S. Mondal, Yoshito Nishi, Naoko Kawano, Ken Ohnita, Yohei Mizuta, Akira Ohtsuru, Shunichi Yamashita, Masamitsu Nakazato, Shigeru Kohno, Impact of Helicobacter Pylori Infection on Gastric and Plasma Ghrelin Dynamics in Humans, The American Journal of Gastroenterology, 2005, 100, 8, 1711

    CrossRef

  7. 7
    Ala I Sharara, Rabeprazole: the role of proton pump inhibitors inHelicobacter pylorieradication, Expert Review of Anti-infective Therapy, 2005, 3, 6, 863

    CrossRef

  8. 8
    Hajime Isomoto, Hiroshi Mukae, Hiroshi Ishimoto, Yukari Date, Yoshito Nishi, Kenichiro Inoue, Akihiro Wada, Toshiya Hirayama, Masamitsu Nakazato, Shigeru Kohno, Elevated Concentrations of alpha-Defensins in Gastric Juice of Patients with Helicobacter pylori Infection, The American Journal of Gastroenterology, 2004, 99, 10, 1916

    CrossRef

  9. 9
    Hajime Isomoto, Vladimir A. Saenko, Yusei Kanazawa, Yoshito Nishi, Akira Ohtsuru, Kenichiro Inoue, Yuko Akazawa, Fuminao Takeshima, Katsuhisa Omagari, Masanobu Miyazaki, Yohei Mizuta, Ikuo Murata, Shunichi Yamashita, Shigeru Kohno, Enhanced Expression of Interleukin-8 and Activation of Nuclear Factor Kappa-B in Endoscopy-negative Gastroesophageal Reflux Disease, The American Journal of Gastroenterology, 2004, 99, 4, 589

    CrossRef

  10. 10
    W.A. de Boer, E.J. Kuipers, J.G. Kusters, Sequential therapy; a new treatment for Helicobacter pylori infection, Digestive and Liver Disease, 2004, 36, 5, 311

    CrossRef

  11. 11
    N. Vakil, F. Lanza, H. Schwartz, J. Barth, Seven-day therapy for Helicobacter pylori in the United States, Alimentary Pharmacology & Therapeutics, 2004, 20, 1
  12. 12
    C Gambaro, C Bilardi, P Dulbecco, E Iiritano, P Zentilin, C Mansi, P Usai, S Vigneri, V Savarino, Comparable Helicobacter pylori eradication rates obtained with 4- and 7-day rabeprazole-based triple therapy: a preliminary study, Digestive and Liver Disease, 2003, 35, 11, 763

    CrossRef

  13. 13
    Kyoichi Adachi, Tomoyuki Hashimoto, Shunji Ishihara, Hirofumi Fujishiro, Shuichi Sato, Hiroshi Sato, Yuji Amano, Shuzo Hattori, Yoshikazu Kinoshita, Comparison of five-day Helicobacter pylori eradication regimens: rabeprazole-based and omeprazole-based regimens with and without omeprazole pretreatment, Current Therapeutic Research, 2003, 64, 7, 412

    CrossRef

  14. 14
    KL GOH, MS ROSAIDA, O SALEM, PL CHEAH, P RANJEEV, YM TAN, M ROSMAWATI, SC CHIN, Efficacy of a 1-week rabeprazoletriple therapy for eradicating Helicobacter pylori and ulcerhealing: an 'in-clinical-practice' study, Chinese Journal of Digestive Diseases, 2003, 4, 4, 204

    CrossRef

  15. 15
    KL GOH, MS ROSAIDA, O SALEM, PL CHEAH, P RANJEEV, YM TAN, M ROSMAWATI, SC CHIN, Efficacy of a 1-week rabeprazole triple therapy for eradicating Helicobacter pylori and ulcer healing: an ‘in-clinical-practice’ study, Chinese Journal of Digestive Diseases, 2003, 4, 4
  16. 16
    Wieslaw J. Bochenek, Suzanne Peters, Polly D. Fraga, Wenjin Wang, Michael E. Mack, Michael S. Osato, Hala M. T. El-Zimaity, Kelly D. Davis, David Y. Graham, Eradication of Helicobacter pylori by 7-Day Triple-Therapy Regimens Combining Pantoprazole with Clarithromycin, Metronidazole, or Amoxicillin in Patients with Peptic Ulcer Disease: Results of Two Double-Blind, Randomized Studies, Helicobacter, 2003, 8, 6
  17. 17
    H. Isomoto, K. Inoue, H. Furusu, A. Enjoji, C. Fujimoto, M. Yamakawa, Y. Hirakata, K. Omagari, Y. Mizuta, K. Murase, S. Shimada, I. Murata, S. Kohno, High-dose rabeprazole–amoxicillin versus rabeprazole–amoxicillin–metronidazole as second-line treatment after failure of the Japanese standard regimen for Helicobacter pylori infection, Alimentary Pharmacology & Therapeutics, 2003, 18, 1
  18. 18
    Hajime Isomoto, Kenichiro Inoue, Hisashi Furusu, Hitoshi Nishiyama, Saburo Shikuwa, Katsuhisa Omagari, Yohei Mizuta, Kunihiko Murase, Ikuo Murata, Shigeru Kohno, Lafutidine, a Novel Histamine H2-Receptor Antagonist, vs. Lansoprazole in Combination with Amoxicillin and Clarithromycin for Eradication of Helicobacter pylori, Helicobacter, 2003, 8, 2
  19. 19
    C. Kositchaiwat, B. Ovartlarnporn, U. Kachintorn, K. Atisook, Low and high doses of rabeprazole vs. omeprazole for cure of Helicobacter pylori infection, Alimentary Pharmacology & Therapeutics, 2003, 18, 10
  20. 20
    REZA MALEKZADEH, SHAHIN MERAT, MOHAMMAD-HASSAN DERAKHSHAN, FARIDEH SIAVOSHI, ABBAS YAZDANBOD, JAVAD MIKAELI, RASOUL SOTOUDEMANESH, MASOUD SOTOUDEH, MOHAMMAD-JAFAR FARAHVASH, SIAVOSH NASSERI-MOGHADDAM, AKRAM POURSHAMS, SHAHAB DOLATSHAHI, BEHNOOSH ABEDI, MASOUD BABAEI, SHAHNAM ARSHI, ALI MAJIDPOUR, Low Helicobacter pylori eradication rates with 4- and 7-day regimens in an Iranian population, Journal of Gastroenterology and Hepatology, 2003, 18, 1
  21. 21
    J. P. Gisbert, S. Khorrami, X. Calvet, J. M. Pajares, Rabeprazole-based therapies in Helicobacter pylori eradication, Alimentary Pharmacology & Therapeutics, 2003, 17, 6
  22. 22
    C. J. Hawkey, J. C. Atherton, H. C. Treichel, B. Thjodleifsson, M. Ravic, Safety and efficacy of 7-day rabeprazole- and omeprazole-based triple therapy regimens for the eradication of Helicobacter pylori in patients with documented peptic ulcer disease, Alimentary Pharmacology & Therapeutics, 2003, 17, 8
  23. 23
    Nicholas J Talley, Shiu Kum Lam, Benjamin Chun Yu Wong, Harry Hua-Xiang Xia, Alternative and rescue treatment regimens for Helicobacter pylori eradication, Expert Opinion on Pharmacotherapy, 2002, 3, 9, 1301

    CrossRef

  24. 24
    Hajime Isomoto, Hisashi Furusu, Masashi Shin, Ken Ohnita, Masanobu Miyazaki, Katsuhisa Omagari, Yohei Mizuta, Kunihiko Murase, Ken-ichiro Inoue, Ikuo Murata, Takehiko Koji, Shigeru Kohno, Enhanced Expression of Transcription Factor E2F in Helicobacter pylori-infected Gastric Mucosa, Helicobacter, 2002, 7, 3
  25. 25
    A. Qasim, C. A. O'Morain, Treatment of Helicobacter pylori infection and factors influencing eradication, Alimentary Pharmacology & Therapeutics, 2002, 16,
  26. 26
    B. C. Y. Wong, W. M. Wong, Y. K. Yee, W. K. Hung, A. W. C. Yip, M. L. Szeto, K. F. Li, P. Lau, F. M. Y. Fung, T. S. M. Tong, K. C. Lai, W. H. C. Hu, M. F. Yuen, C. K. Hui, S. K. Lam, Rabeprazole-based 3-day and 7-day triple therapy vs. omeprazole-based 7-day triple therapy for the treatment of Helicobacter pylori infection, Alimentary Pharmacology & Therapeutics, 2001, 15, 12